Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease

Journal of Managed Care and Specialty Pharmacy

Volumn 20, Issue 10, 2014, Pages 1036-1045

  Spence, Michele M ^a   Makarem, Abir F ^a   Reyes, Stacie L ^a   Rosa, Lisa L ^a   Nguyen, Courtney ^a   Oyekan, Elizabeth A ^a   Kiyohara, Alan T ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHLORPROPAMIDE; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; GLIBENCLAMIDE; GLIPIZIDE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PIOGLITAZONE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CLINICAL OUTCOME; CLINICAL PHARMACY; CONSULTATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PRESCRIPTION; PROGRAM EVALUATION; RETROSPECTIVE STUDY; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; COST CONTROL; ECONOMICS; METABOLISM; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; UNITED STATES;

ADULT; AGED; CALIFORNIA; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY ARTERY DISEASE; COST SAVINGS; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES;

EID: 84926334962     PISSN: 23760540     EISSN: 23761032     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.10.1036     Document Type: Article

References (26)

1. Wood B. Medication adherence: the real problem when treating chronic conditions. US Pharm. 2012;37(4 Compliance Suppl):S3-S6. Available at: http:// www.uspharmacist.com/content/s/200/c/33457/. Accessed August 6, 2014.
2. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
3. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41. Available at: http://archinte.jamanetwork. com/article.aspx?articleid=410956. Accessed August 6, 2014.
4. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-61. Available at: http://jama.jamanetwork.com/article. aspx?articleid=195142. Accessed August 6, 2014.
5. Curkendall SM, Thomas N, Bell KF, Juneau PL, Weiss AJ. Predictors of medication adherence in patients with type 2 diabetes mellitus. Curr Med Res Opin. 2013;29(10):1275-86.
6. Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff (Millwood). 2012;31(8):1836-46.
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487-97.
8. Nair KV, Belletti DA, Doyle JJ, et al. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence. 2011;5:195-206. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090381/pdf/ppa-5-195.pdf. Accessed August 6, 2014.
9. Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I. The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Pref Adherence. 2012;6:323-29. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340117/pdf/ppa-6-323.pdf. Accessed August 6, 2014.
10. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):256-371. Available at: http://jama.jamanetwork.com/article.aspx?articleid=204402. Accessed August 6, 2014.
11. Brennan TA, Dollear TJ, Hu M, et al. An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients. Health Aff (Millwood). 2012;31(1):120-29.
12. Odegard PS, Christensen DB. MAP study: RCT of a medication adherence program for patients with type 2 diabetes. J Am Pharm Assoc (2003). 2012;52(6):753-62.
13. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11(4):253-60. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/15839185. Accessed August 6, 2014.
14. Ip EJ, Shah BM, Yu J, Chan J, Nguyen LT, Bhatt DC. Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health Syst Pharm. 2013;70(10);877-86. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/23640349. Accessed August 6, 2014.
15. Oyekan E, Nimalasuriya A, Martin J, Scott R, Dudl RJ, Green K. The B-SMART appropriate medication-use process: a guide for clinicians to help patients-Part 1: Barriers, solutions, and motivation. Perm J. 2009;13(1): 62-69. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3034468/. Accessed August 6, 2014.
16. Oyekan E, Nimalasuriya A, Martin J, Scott R, Dudl RJ, Green K. The B-SMART appropriate medication-use process: a guide for clinicians to help patients-Part 2: Adherence, relationships, and triage. Perm J. 2009;13(4):50-54. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2911835/. Accessed August 6, 2014.
17. Oyekan ES, DiGangi L. The B-Smart Handbook with Pharmaceutical Pearls. 2009 ed. Los Angeles, CA: Kaiser Permanente Southern California; 2008.
18. U.S. Department of Labor, Bureau of Labor Statistics. Occupation employment and wages, May 2013. 29-1051 pharmacists. Revised April 1, 2014. Available at: http://www.bls.gov/oes/current/oes291051.htm#st. Accessed August 6, 2014.
19. Ash AS, Ellis RP, Pope GC, et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev. 2000;21(3):7-28. Available at: http://www.cms.gov/HealthCareFinancingReview/Downloads/00springpg7. pdf. Accessed August 6, 2014.
20. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1-S45. Available at: https://circ.ahajournals.org/content/ early/2013/11/11/01.cir.0000437738.63853.7a.full.pdf. Accessed August 6, 2014.
21. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacother. 2005;25(8):1035-43.
22. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macro- vascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. Available at: http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC27454/. Accessed August 6, 2014.
23. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
24. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65.
25. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846-57.
26. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7-8):1208-88.